Thursday, September 30, 2010

Glaxo's Avandia Cover-up

Paul Thacker, a former congressional investigator for the United States Senate Finance Committee, tells how GSK concealed the risks of its blockbuster diabetes drug, Avandia. Read it in Mother Jones.

No comments:

Post a Comment